Today, the House Energy & Commerce Committee holds a hearing entitled "Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain" that offers another opportunity to advance substantive reform.

CFIF applauds the Committee, and members Brett Guthrie (R - Kentucky) and Morgan Griffith (R - Virginia), for their collective efforts on this issue of affordability.  In that effort, we also continue our own effort to emphasize the importance of avoiding destructive government price controls, which only serve to make lifesaving pharmaceuticals less available to Americans, not more available.  It's also critical to maintain focus on ongoing reform in the pharmaceutical benefit manager (PBM) arena, which actually can bring improvement, as we've consistently…[more]